VanHimbergen Robert M 4
4 · Elanco Animal Health Inc · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Elanco CFO Robert VanHimbergen Receives Stock Award
What Happened
- Robert M. VanHimbergen, Elanco EVP and Chief Financial Officer, was granted 9.92 deferred stock units on May 15, 2026. The units were reported at $19.86 per share for a total reported value of about $197. This transaction is an award/grant (derivative deferred stock units), not an open-market purchase or sale.
Key Details
- Transaction date and price: 2026-05-15 — 9.92 units @ $19.86 (total ≈ $197).
- Filing date: Form 4 filed 2026-05-19 (timely within required filing window).
- Shares owned after transaction: not specified in the provided filing details.
- Transaction code/type: A (award/grant) — derivative instrument (deferred stock units).
- Footnotes: F1 — each deferred stock unit equals the right to one share or cash equivalent. F2 — units settle in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
Context
- Deferred stock units are a form of compensation that convert to shares or cash at a later date; they do not represent immediate open-market buying or selling. This small-value award (~$197) appears to be a routine compensation grant and should not be interpreted on its own as a signal of insider sentiment.
Insider Transaction Report
Form 4
VanHimbergen Robert M
EVP and CFO
Transactions
- Award
Deferred Stock Units
[F1][F2]2026-05-15$19.86/sh+9.92$197→ 84.42 total→ Common Stock (9.92 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- [F2]Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen|2026-05-19